1. 1) MacDougall C. Protein synthesis inhibitors and miscellaneous antibacterial agents. Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e. (Brunton LL, Hilal-Dandan R, Knollmann BC eds.) McGraw Hill, NY (2017).
2. 2) DrugBank. “Clindamycin phosphate.”: ‹https://go.drugbank.com/salts/DBSALT000778›, accessed 02 Jan, 2023.
3. 3) Luchian I, Goriuc A, Martu MA, Covasa M. Clindamycin as an alternative option in optimizing periodontal therapy. Antibiotics (Basel), 10, 814 (2021).
4. 4) Ghaffari A, Manafi A, Moghimi HR. Clindamycin phosphate absorption from nanoliposomal formulations through third-degree burn eschar. World J. Plast. Surg., 4, 145–152 (2015).
5. 5) Karczewski A, Feitosa SA, Hamer EI, Pankajakshan D, Gregory RL, Spolnik KJ, Bottino MC. Clindamycin-modified triple antibiotic nanofibers: a stain-free antimicrobial intracanal drug delivery system. J. Endod., 44, 155–162 (2018).